Stock Market Stories and Insights

<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>CB</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
Cornerstone Building Tangible Asset Value is relatively stable at the moment as compared to the past year. Cornerstone Building reported last year Tangible Asset Value of 2.48 Billion. As of 08/11/2020, Working Capital is likely to grow to about 641.7 M, while Market Capitalization is likely to drop slightly above 1.1 B. The fundamental reasoning behind this short post is to break down our forecasting of Cornerstone for retail investors. We will try to forecast Cornerstone Building outlook for September.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:0.9em;padding-top: 12px;;'>LND</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
It looks like Farmer Brothers will continue to recover much faster as its share price surged up 0.33% today to Landec's 3.6822%. As many rational traders are trying to avoid consumer defensive space, it makes sense to go over Landec a little further and understand how it stands against Farmer Brothers and other similar entities. We are going to analyze some of the competitive aspects of both Landec and Farmer.
<div class='circular--portrait-small' style='font-weight: 700;background:#347AFC;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>FT</div>
  2 days ago at Macroaxis 
By Gabriel Shpitalnik
Fulcrum Therapeutics is currently generating 0.2146% in daily expected returns and assumes 5.6248% risk (volatility on return distribution) over the 60 days horizon. As many adventurous traders are excited about healthcare space, it is only fair to go over the risk of shorting Fulcrum Therapeutics based on its current volatility spike. We are going to analyze if the current expected returns justify Fulcrum Therapeutics' volatility.
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;padding-top: 10px;;'>LH</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
As many rational traders are trying to avoid technology space, it makes sense to digest Lumentum Holdings a little further and understand how it stands against Knowles and other similar entities. We are going to discuss some of the competitive aspects of both Lumentum and Knowles.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>CS</div>
  2 days ago at Macroaxis 
By Ellen Johnson
Casper Sleep is scheduled to announce its earnings today. As many millenniums are trying to avoid consumer cyclical space, it makes sense to sum up Casper Sleep a little further and try to understand its current market patterns. Here we also measure the ability of Casper Sleep to meet its long-term debt obligations, such as interest payments on debt, the final principal payment on the debt, and any other fixed obligations like lease payments.
<div class='circular--portrait-small' style='font-weight: 700;background:#169D0B;color: #E6E6FA;font-size:1.1em;padding-top: 10px;;'>CG</div>
  2 days ago at Macroaxis 
By Ellen Johnson
While some baby boomers are getting worried about consumer cyclical space, it is reasonable to sum up Canada Goose Holdings. We will evaluate if Canada Goose shares are reasonably priced going into September. Here I will also expose some primary fundamental factors affecting Canada Goose's services, and outline how it will impact the outlook for investors this year.
<div class='circular--portrait-small' style='font-weight: 700;background:#689CFD;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>SS</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
Given the investment horizon of 90 days, Strata Skin is expected to generate 1.18 times less return on investment than the market. In addition to that, the company is 3.86 times more volatile than its market benchmark. It trades about 0.04 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.19 per unit of volatility. As many old-fashioned traders are trying to avoid healthcare space, it makes sense to outline Strata Skin Sciences a little further and try to understand its current volatility patterns. What exactly are Strata Skin shareholders getting in September?
<div class='circular--portrait-small' style='font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;padding-top: 10px;;'>LE</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
As many millenniums are trying to avoid consumer defensive space, it makes sense to go over Lincoln Educational Services a little further and try to understand its current market patterns. For some short-term oriented investors Lincoln Educational may be the right move right now, Let's take a closer look. The returns on the market and returns on Lincoln Educational appear slightly correlated for the last few months. The appearance of strong basic indicators of the company suggests a short-term price swing for investors of Lincoln. Lincoln Educational is scheduled to announce its earnings today. The next earnings report is expected on the 12th of November 2020.
<div class='circular--portrait-small' style='font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:0.9em;padding-top: 12px;;'>RDC</div>
  2 days ago at Macroaxis 
By Achuva Shats
It looks like Verizon Communications will continue to recover much faster as its share price surged up 0.79% today to Radcom's 3.4682%. As many millenniums are getting more into communication services space, we are going to summarize Radcom and Verizon Communications as potential short-term trade. We are going to summarize some of the competitive aspects of both Radcom and Verizon.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>SS</div>
  2 days ago at Macroaxis 
By Achuva Shats
As many millenniums are trying to avoid financial services space, it makes sense to digest Safeguard Scientifics Inc a little further and try to understand its current market patterns. We are going to cover the possibilities of making Safeguard Scientifics into your portfolio. Is the firm valuation justified? Here we go over Safeguard Scientifics New perspective on valuation to give you a better outlook on taking a position in this stock.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page